3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Colorectal Neoplasms
13
Stomach Neoplasms
11
Esophageal Neoplasms
8
Barrett Esophagus
6
Gastrointestinal Neoplasms
5
Rectal Neoplasms
3
Colonic Neoplasms
3
Precancerous Conditions
2
Lung Neoplasms
2
Hemorrhage
2
Gastric GIST
2
Esophageal Squamous Cell Carcinoma
2
Colonic Polyps
2
Carcinoma, Non-Small-Cell Lung
2
Adenoma
2
Adenocarcinoma Of Esophagus
2
Tobacco Use Disorder
1
Submucosal Tumor of Stomach
1
Small Size Gastrointestinal Stromal Tumors
1
Small Cell Lung Carcinoma
1
Rectal Neuroendocrine Tumors
1
Polyps
1
Pituitary Neoplasms
1
Personal Satisfaction
1
Pathological Conditions, Anatomical
1
Paranasal Sinus Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms, Glandular and Epithelial
1
Interventions
Etoposide
153
Carboplatin
140
Cisplatin
103
Topotecan
74
durvalumab
48
atezolizumab
45
Irinotecan
44
pembrolizumab
38
Paclitaxel
34
Nivolumab
33
Radiotherapy
29
anlotinib
23
PM 01183
21
Gemcitabine
21
Drug Therapy
20
apatinib
19
Ipilimumab
18
Docetaxel
17
Temozolomide
16
Platinum
16
Radiosurgery
15
Pemetrexed
14
toripalimab
13
tislelizumab
13
olaparib
13
Bevacizumab
13
amrubicin
11
Magnetic Resonance Spectroscopy
11
Cyclophosphamide
11
rovalpituzumab tesirine
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Small Cell Lung Carcinoma
×
Endoscopic Mucosal Resection
×
Clear all
NCT00751660
2012-03-09
Pan Can
British Columbia Cancer Agency
Phase NA
Unknown
2,504 enrolled